Wilhelmus Cm Groenhuysen, Chief Operating Officer at NovoCure Ltd (NVCR), sold 56,724 shares at $105.62 ($6.1M) on 2020-09-16, disclosed to the SEC on 2020-09-18.
Open-market sale of $6.1M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.62 | 800 | $84K | 1.4% |
| 2 | $105.80 | 2,000 | $212K | 3.5% |
| 3 | $106.05 | 500 | $53K | 0.9% |
| 4 | $106.55 | 2,100 | $224K | 3.7% |
| 5 | $106.67 | 3,077 | $328K | 5.4% |
| 6 | $106.67 | 3,077 |
| $328K |
| 5.4% |
| 7 | $107.18 | 633 | $68K | 1.1% |
| 8 | $107.18 | 633 | $68K | 1.1% |
| 9 | $107.65 | 3,279 | $353K | 5.8% |
| 10 | $107.65 | 3,279 | $353K | 5.8% |
| 11 | $107.66 | 5,123 | $552K | 9.0% |
| 12 | $107.66 | 5,123 | $552K | 9.0% |
| 13 | $107.97 | 600 | $65K | 1.1% |
| 14 | $108.57 | 1,000 | $109K | 1.8% |
| 15 | $108.71 | 1,700 | $185K | 3.0% |
| 16 | $109.16 | 200 | $22K | 0.4% |
| 17 | $109.54 | 600 | $66K | 1.1% |
| 18 | $109.55 | 400 | $44K | 0.7% |
| 19 | $105.28 | 300 | $32K | 0.5% |
| 20 | $106.68 | 500 | $53K | 0.9% |
| 21 | $107.94 | 2,232 | $241K | 3.9% |
| 22 | $107.94 | 2,232 | $241K | 3.9% |
| 23 | $108.79 | 7,868 | $856K | 14.0% |
| 24 | $108.79 | 7,868 | $856K | 14.0% |
| 25 | $109.81 | 1,500 | $165K | 2.7% |
| 26 | $110.52 | 100 | $11K | 0.2% |
| Total | $107.86 avg | 56,724 | $6.1M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |